Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

NCT00793650 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Melphalan
PROCEDURE: Autologous PBSC Transplant

Sponsor

Emory University

Collaborators

[object Object]